on 17 Nov 2020
Last Applicant/ Owned by
Tokyo University, 7-3-1, Hongo,
JP
Serial Number
79274176 filed on 23rd Jul 2019
Registration Number
6197550 registered on 17th Nov 2020
Correspondent Address
Sandra Epp Ryan
Filing Basis
No Filing Basis
Disclaimer
NO DATA
The color(s) blue, blue-grey and black is/are claimed as a feature of the mark. The colors blue, blue-grey and black are claimed as features of the mark; The mark consists of the waved circle with five convex parts and five concave parts in blue-grey, the waved semicircle with three convex parts and three concave parts in blue and the word "OriCiro" in black. The mark consists of a design of a w Read More
Chemical reagents for genetic research, other than for medical or veterinary purposes; chemical reagents, other than for medical or veterinary purposes; reagents for scientific and research use, namely, for DNA amplification; reagents for genetic research purposes, other than for medical or veterinary purposes; reagents for research purposes; reagents for scientific purposes for use in nucleic acid isolation and purification; reagents for scientific purposes; chemicals for use in the manufacture of pharmaceuticals; industrial chemicals; test paper, chemical; reagent paper, other than for medical or veterinary purposes
Chemical reagents for medical purposes; diagnostic reagents for medical purposes; reagents for use in medical genetic testing; reagents, for medical purposes; diagnostic preparations for medical purposes; pharmaceutical preparations, for the treatment of diseases caused by genetic disorder; reagent paper for medical purposes
Genetic specimen samplers, other than for medical use, namely, testing sample collection equipment in the nature of wipes and swabs for use in diagnostic testing, not for medical purposes; DNA chips; DNA chip making apparatus being a DNA microarray apparatus; DNA synthesizing apparatus, namely, DNA microarray; DNA analyzing apparatus, namely, laboratory research instruments for DNA analysis; scientific apparatus and instruments and laboratory apparatus for research purposes, namely, polymerase chain reaction thermocyclers used to amplify DNA, for analytical and research purposes; DNA fragmentation apparatus, namely, laboratory apparatus to separate or for breaking DNA strands into pieces; gene testing equipment for research purposes, namely, electrical equipment for the genetic modification of cells for research purposes; analytical apparatus, namely, laboratory apparatus for extracting DNA for use in laboratory; laboratory kits for use with reagents for DNA amplification comprised primarily of laboratory apparatus for extracting DNA and laboratory devices for detecting genetic sequences; laboratory kits for use with reagents for genetic research comprised primarily of laboratory apparatus for extracting DNA and laboratory devices for detecting genetic sequences; laboratory apparatus and instruments in the form of kits comprised primarily of laboratory apparatus for extracting DNA and laboratory devices for detecting genetic sequences; measuring or testing machines and instruments, namely, scientific apparatus and instruments for measuring relative DNA, RNA and protein
Custom treatment of materials in the nature of syntheses of DNA; custom treatment of materials in the nature of syntheses of RNA; custom treatment of materials in the nature of syntheses of nucleic acids; custom treatment of materials in the nature of amplification of DNA; custom manufacture of chemicals; processing of chemical reagents; processing of medicinal materials, namely, medicinal plants; custom manufacture, namely, extraction, purification and syntheses of pharmaceuticals; custom manufacture of pharmaceuticals; treatment of biopharmaceutical materials by means of DNA engineering; providing material treatment information
Testing, inspection, research or development services in the fields of genes, namely, research in the fields of genetics, gene therapy, DNA and chemical and biological production methods; consultancy and information services relating to testing, inspection, research or development services in the fields of genes, namely, scientific research consulting in the fields of genetics, gene therapy, DNA and chemical and biological production methods; scientific research in the fields of genetics and genetic engineering; testing, inspection, research or development services in the fields of chemistry, namely, scientific research and development in the fields of chemistry; consultancy and information services relating to testing, inspection, research or development services in the fields of chemistry, namely, chemistry consultation; testing, inspection, research or development services in the fields of pharmaceuticals, namely, testing, inspection, research, or development of pharmaceutical preparations for gene therapy including DNA and RNA-based therapy and vaccines; consultancy and information services relating to testing, inspection, research or development services in the fields of pharmaceuticals, namely, scientific research consulting in the fields of pharmaceuticals; testing, inspection or research on agriculture, livestock breeding or fisheries; testing or research on prevention of pollution; scientific laboratory services
No 79274176
No Service Mark
No 20432.108USI
No
No
No
No
No
No
No
No
26.01.28 -
Miscellaneous circular designs with an irregular circumference
The mark consists of a design of a waved circle with five convex parts and five concave parts in blue-grey, interwoven with a waved semicircle with three convex parts and three concave parts in blue to the left of the word "ORICIRO" in black. The color white represents background, outlining, shading, and/or transparent area is not part of the mark.
Status Date | Action Taken |
---|---|
20th Jan 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
20th Jan 2022 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
20th Jan 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
20th Jan 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
21st Mar 2021 | FINAL DECISION TRANSACTION PROCESSED BY IB |
26th Feb 2021 | FINAL DISPOSITION NOTICE SENT TO IB |
26th Feb 2021 | FINAL DISPOSITION PROCESSED |
17th Feb 2021 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
11th Dec 2020 | NEW REPRESENTATIVE AT IB RECEIVED |
17th Nov 2020 | REGISTERED-PRINCIPAL REGISTER |